Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of QA108 granules for intermediate age-related macular degeneration
CTR20250377Phase 3Active
- Sponsor
- Qiwei Biotech
- Start
- Jul 2025
- Countries
- 1
01
Overview
A Phase 3 trial of QA108 in age-related macular degeneration (AMD), sponsored by Qiwei Biotech. Started Jul 2025; status: active.
02
Drugs
QA108
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on CTR20250377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250377.